Jennison Associates
KIN

Jennison Associates’s Kindred Biosciences, Inc. KIN Stock Holding History

Jennison Associates’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,173,893
Closed -$11.3M – 755
2015
Q3 		$11.3M Buy
2,173,893
+11,726
+0.5% +$72.3K 0.01% 500
2015
Q2 		$14.7M Buy
2,162,167
+14,985
+0.7% +$106K 0.01% 490
2015
Q1 		$15.3M Buy
2,147,182
+4,716
+0.2% +$32.5K 0.01% 465
2014
Q4 		$16M Sell
2,142,466
-90,259
-4% -$766K 0.01% 459
2014
Q3 		$20.7M Buy
2,232,725
+725,240
+48% +$9.8M 0.02% 431
2014
Q2 		$28.1M Buy
1,507,485
+599,295
+66% +$10.2M 0.03% 405
2014
Q1 		$16.8M Buy
908,190
+6,416
+0.7% +$122K 0.02% 455
2013
Q4 		$10M Buy
+901,774
New +$10.7M 0.01% 485

Other funds holding KIN

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jennison Associates's KIN Position: Q4 2015 in Review

Jennison Associates sold out of Kindred Biosciences, Inc. (KIN) in Q4 2015, closing a stake of 2,173,893 shares — an estimated $11.3M sold.

Jennison Associates first reported a position in KIN in Q4 2013 and held it in 8 quarters. The position peaked at $28.1M in Q2 2014. 50 funds tracked by Wall St. Rank hold KIN as of Q4 2015.

  • Jennison Associates reported no remaining Kindred Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • Jennison Associates sold 2,173,893 Kindred Biosciences, Inc. shares in Q4 2015, an estimated $11.3M.
  • Jennison Associates first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 8 quarters.
  • Jennison Associates's Kindred Biosciences, Inc. position peaked at $28.1M in Q2 2014.
  • 50 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2015.

Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.